| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/15/2010 | US20100179124 Thieno-pyridine derivatives as mek inhibitors |
| 07/15/2010 | US20100179123 Thienopyrimidines useful as aurora kinase inhibitors |
| 07/15/2010 | US20100179121 1,3-dihydroxy substituted phenylamide glucokinase activators |
| 07/15/2010 | US20100179097 Use of kauranes compounds in the manufacture of medicament |
| 07/15/2010 | US20100178363 Agent for preventing bleeding from cerebral cortical vein |
| 07/15/2010 | US20100178338 Stabilized pharmaceutical compositions comprising atorvastatin |
| 07/15/2010 | US20100178334 Oral Pharmaceutical Dosage Form Comprising as Active Ingredients a Proton Pump Inhibitor together with Acetyl Salicyclic Acid |
| 07/15/2010 | US20100178287 Use of coagulation proteins to lyse clots |
| 07/15/2010 | CA2747680A1 Solutions for volume therapy |
| 07/15/2010 | CA2747519A1 Anti-fxi antibodies and methods of use |
| 07/15/2010 | CA2746350A1 Anti-rhd monoclonal antibodies |
| 07/14/2010 | EP2206772A2 Method of collecting placental stem cells |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2206534A1 Dibenzocycloheptanone derivatives und pharmaceutical agents containing these compounds |
| 07/14/2010 | EP2206533A2 3'- (2z)- 1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene hydrazino -2'-hydroxy- 1,1'-biphenyl -3-carboxylic acid bis-(monoethanolamine) |
| 07/14/2010 | EP2206511A1 Protein a compositions and methods of use |
| 07/14/2010 | EP2206504A1 Stable bicarbonate ion-containing drug solution |
| 07/14/2010 | EP2205616A1 Novel sulfated oligosaccharide derivatives |
| 07/14/2010 | EP2205604A1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders |
| 07/14/2010 | CN1935235B Chinese medicine injection preparation and its preparing method |
| 07/14/2010 | CN101778623A Hemostatic agent composition and method of delivery |
| 07/14/2010 | CN101775076A Method for preparing hydroxyethyl starch |
| 07/14/2010 | CN101775063A Saponins compound and application thereof |
| 07/14/2010 | CN101775028A Method for gathering and purifying agrimonine in agrimony |
| 07/14/2010 | CN101773660A Medicament containing anubi-polypeotide |
| 07/14/2010 | CN101773600A Traditional Chinese medicine composition for invigorating vital energy, nourishing blood, regulating menstruation and stopping leukorrhagia as well as quality control method |
| 07/14/2010 | CN101773591A Medicine for activating blood, removing stasis and treating stroke |
| 07/14/2010 | CN101773564A Method for extracting alkaloid from Semen hoveniae and method for purifying Semen hoveniae alkaloid |
| 07/14/2010 | CN101773545A Leucocyte increasing medicament containing batyl alcohol |
| 07/14/2010 | CN101773528A Preparation method of total terpene lactones with low phenolic acid |
| 07/14/2010 | CN101773521A Method for purifying deer serum |
| 07/14/2010 | CN101773508A Stable Trifusal pharmaceutical composition |
| 07/14/2010 | CN101773496A New application of cimetidine |
| 07/14/2010 | CN101773489A Application of citric acid diethyl ester in preparation of anticoagulant medicament |
| 07/14/2010 | CN101543567B Chinese medicinal preparation for treating cerebral thrombosis |
| 07/14/2010 | CN101390876B Preparation method of natural montmorillonite emergency haemostatic for external use |
| 07/13/2010 | US7754879 Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier |
| 07/13/2010 | US7754855 comprising a full-length human erythropoietin protein joined without an intervening peptide linker to a human immunoglobulin domain; making fusion proteins comprising a cytokine or growth factor fused to an immunoglobulin domain; treating deficient hematocrit; purification |
| 07/13/2010 | US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12) |
| 07/13/2010 | US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2) |
| 07/13/2010 | US7754711 Pyridazine derivatives and their use as therapeutic agents |
| 07/13/2010 | US7754709 Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds |
| 07/13/2010 | US7754701 toothpastes, mouthwashes, chewing gums, tableted candy, for inhibiting induction of dental caries |
| 07/13/2010 | US7754682 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders |
| 07/13/2010 | US7754238 Delivery of microparticle-conjugated drugs for inhibition of stenosis |
| 07/13/2010 | US7754215 used for the prevention of acute arterial thrombotic syndromes; do not directly block the GPIb-vWF axis or the GPIIb-IIIa receptor; restenosis, hyperplasia after agioplasty, atherectomy or arterial stenting |
| 07/13/2010 | US7754200 Phosphate transport inhibitors |
| 07/13/2010 | CA2557536C Amino alcohol compound |
| 07/13/2010 | CA2481365C Occlusive composition comprising a poly (2-cyanoacrylate) monomer |
| 07/13/2010 | CA2446820C Novel pyrrole derivatives as pharmaceutical agents |
| 07/13/2010 | CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 07/13/2010 | CA2440979C Spirolaximes for use in the treatment of pathologies that respond to ppar-.gamma. receptor activation |
| 07/13/2010 | CA2432145C Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 07/13/2010 | CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 07/13/2010 | CA2347713C Contulakin-g, analogs thereof and uses therefor |
| 07/13/2010 | CA2345932C Peptide-based carrier devices for stellate cells |
| 07/13/2010 | CA2259724C Monoclonal antibody which is specific for activated coagulation factor vii, and its use |
| 07/13/2010 | CA2176742C Composition for the in vivo production of therapeutic products |
| 07/08/2010 | WO2010078469A2 Sand fly salivary proteins as novel factor xa inhibitors and methods of use |
| 07/08/2010 | WO2010078285A2 Pharmaceutical compositions and methods of treating neurological insults |
| 07/08/2010 | WO2010077867A2 Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus |
| 07/08/2010 | WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/08/2010 | WO2010076517A1 Erythrocytes containing factor viii, preparation and uses |
| 07/08/2010 | WO2009143039A3 Heterocyclic compounds as factor ixa inhibitors |
| 07/08/2010 | US20100174076 Coumarin derivatives useful as tnf alpha inhibitors |
| 07/08/2010 | US20100173994 Synthesis of triethylenetetramines |
| 07/08/2010 | US20100173969 Therapeutic agent |
| 07/08/2010 | US20100173947 New Indications for Direct Thrombin Inhibitors |
| 07/08/2010 | US20100173905 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome |
| 07/08/2010 | US20100173899 Dipeptide analogs as coagulation factor inhibitors |
| 07/08/2010 | US20100173847 Tfpi inhibitors and methods of use |
| 07/08/2010 | US20100173835 Peptides for Treatment of Obesity |
| 07/08/2010 | US20100173831 Factor viii polymer conjugates |
| 07/08/2010 | US20100173830 Factor viii polymer conjugates |
| 07/08/2010 | US20100173022 Composition for the treatment of diabetes mellitus and metabolic syndrome |
| 07/08/2010 | US20100172891 Recombinant human blood coagulation factor VIII protein, composition, use of a recombinant factor VIII protein, use of a composition, method of obtaining a recombinant human blood coagulation factor VIII protein and use thereof |
| 07/08/2010 | US20100172867 Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds |
| 07/08/2010 | CA2748411A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators |
| 07/08/2010 | CA2746221A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/07/2010 | EP2204387A1 Novel chondroitin sulfate having decreased molecular weight and use thereof |
| 07/07/2010 | EP2204181A2 Protease inhibitors |
| 07/07/2010 | EP1873153B1 3-azetidinecarboxylic acid derivatives for use as immunosuppressants |
| 07/07/2010 | EP1597244B1 Ethynyl derivatives serving as factor xa inhibitors |
| 07/07/2010 | EP1470218B1 Corona-virus-like particles comprising functionally deleted genomes |
| 07/07/2010 | CN1850976B Glucose kinase derivant and its preparing method |
| 07/07/2010 | CN101772496A Substituted oxazolidinones and the use thereof |
| 07/07/2010 | CN101768580A Novel fibrinolysin and preparation method and use thereof |
| 07/07/2010 | CN101768155A Derivatives containing (aminomethyl-five-membered heterocyclo-4-carbonyl)-pyrrolidine-2-carboxylic acid, preparation method thereof and use thereof |
| 07/07/2010 | CN101768130A Derivatives containing aminomethyl-5-membered aromatic heterocycle-4-carboxylic acid, preparation method, drug combination and application thereof |
| 07/07/2010 | CN101766810A Medical preparation containing recombinant human granulocytecolony stimulating factor |
| 07/07/2010 | CN101766804A Chinese herbal composite for epistaxis treatment and preparation method thereof |
| 07/07/2010 | CN101766799A Ginseng-monkshood centipede health wine |
| 07/07/2010 | CN101766747A Miao nationality linimentum for treating haemorrhoid and preparation method thereof |
| 07/07/2010 | CN101766693A Process for extracting total flavonoid from lotus plumule with high efficiency |
| 07/07/2010 | CN101766684A Chinese medicine composite for treating cardiovascular diseases and preparation method thereof |
| 07/07/2010 | CN101766677A Chinese medicine for dredge and hydragogue of gynecopathy and preparation method thereof |
| 07/07/2010 | CN101766674A Medicament composition for preventing and controlling restenosis after intracoronary stent implantation |
| 07/07/2010 | CN101766671A Pharmaceutical composition for preventing and treating restenosis after coronary stent implantation and preparation method thereof |
| 07/07/2010 | CN101766670A Rhodiola rosea polyphenol microcapsule and preparation method |
| 07/07/2010 | CN101766662A Process for efficiently concentrating cordycepin |